Brian Connolly
Direttore Tecnico/Scientifico/R&S presso SPYRE THERAPEUTICS, INC.
Profilo
Brian Connolly currently works at Spyre Therapeutics, Inc., as Chief Technical Officer from 2023.
Mr. Connolly also formerly worked at Achaogen, Inc., as Associate Director from 2017 to 2018, Viewpoint Therapeutics, Inc., as Senior Director-Operations from 2019 to 2020, Catalyst Biosciences, Inc., as Senior Director-CMC Development & Manufacturing from 2020 to 2021, and Prometheus Biosciences, Inc., as VP, Head-Chemistry, Manufacturing & Controls from 2021 to 2023.
Mr. Connolly received his undergraduate degree from the University of California.
Posizioni attive di Brian Connolly
| Società | Posizione | Inizio |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 27/11/2023 |
Precedenti posizioni note di Brian Connolly
| Società | Posizione | Fine |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Corporate Officer/Principal | 01/10/2023 |
| CATALYST BIOSCIENCES | Corporate Officer/Principal | 01/01/2021 |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Direttore operativo | 01/01/2020 |
| ACHAOGEN | Corporate Officer/Principal | 01/01/2018 |
Formazione di Brian Connolly
| University of California | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Brian Connolly
